NFKB1 and inflammatory bowel disease: As HBD2 production is reduced with deletion of NF-κB binding sites in the promoter region of the HBD2 gene [28], we investigated whether there were more genetic polymorphisms at these sites in IBD patients than controls, but found no differences.